LGALS9 and Alzheimer disease: Understanding the causal relationships among Gal‐9, Aβ aggregation, microglia‐induced inflammation, and neurodegeneration may help uncover potential peripheral biomarkers for the early diagnosis of AD and the development of therapeutic strategies to alleviate neurodegeneration in AD.